Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

Michael Koldehoff, MD, Nina K Steckel, MD, Christina Maniera, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD, PhD

Blood (2013) 122 (21): 4585.

https://doi.org/10.1182/blood.V122.21.4585.4585

Published: 2013

Journal Articles

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina K. Steckel, MD, Yael Hegerfeldt, MD, Markus Ditschkowski, Sandra Christoph, MD, Tanja Gromke, Rudof Stefan Ross, Hellmut Ottinger, Dietrich Beelen

Blood (2012) 120 (21): 1635.

https://doi.org/10.1182/blood.V120.21.1635.1635

Published: 2012

Journal Articles

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet H. Elmaagacli, Nina K. Steckel, Michael Koldehoff, Yael Hegerfeldt, Rudolf Trenschel, Markus Ditschkowski, Sandra Christoph, Tanja Gromke, Lambros Kordelas, Hellmut D. Ottinger, Rudolf S. Ross, Peter A. Horn, Susanne Schnittger, Dietrich W. Beelen

Blood (2011) 118 (5): 1402–1412.

https://doi.org/10.1182/blood-2010-08-304121

Published: 2011

Journal Articles

Matched Unrelated Donor Allogeneic Stem Cell Transplantation in High Risk Acute Lymphoblastic Leukemia (ALL) After a Preparative Regimen of Hyperfractionated Total Body Irradiation and High-Dose Etoposide – A Feasibility Study within the German Multicenter Study Group for Adult ALL.

Dietrich W. Beelen, MD, PhD, Renate Arnold, MD, PhD, Theis Terwey, MD, Nina K. Steckel, MD, Nicola Goekbuget, MD, Hoelzer Dieter, MD, PhD

Blood (2009) 114 (22): 3389.

https://doi.org/10.1182/blood.V114.22.3389.3389

Published: 2009

Journal Articles

TLR9 but Not NOD2/CARD15 Gene Polymorphism Influence Outcome in AML-Patients Transplanted From HLA-Identical Sibling Donors.

Ahmet H Elmaagacli, Michael Koldehoff, Tania Gromke, Nina K Steckel, Dietrich W. Beelen, MD

Blood (2009) 114 (22): 1191.

https://doi.org/10.1182/blood.V114.22.1191.1191

Published: 2009

Journal Articles

PKC412 Shows Strong Anti-myeloma effects in in-Vitro-Studies

Ahmet H Elmaagacli, Michael Koldehoff, Nina K Steckel, Dietrich Beelen

Blood (2008) 112 (11): 5172.

https://doi.org/10.1182/blood.V112.11.5172.5172

Published: 2008

Journal Articles

Reduced Incidence of Severe Acute GVHD in Patients Transplanted from Donors with IL23R (Arg381Gln) Gene Variant.

Ahmet H. Elmaagacli, MD, Michael Koldehoff, M.D., Nina K. Steckel, M.D., Dietrich Beelen, M.D.

Blood (2007) 110 (11): 1061.

https://doi.org/10.1182/blood.V110.11.1061.1061

Published: 2007

Journal Articles

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Ahmet Elmaagacli, MD, Rudolf Peceny, M.D., Michael Koldehoff, M.D., Hellmut Ottinger, M.D., Rudolf Trenschel, M.D., Nina K. Steckel, M.D., Dietrich W. Beelen, M.D.

Blood (2006) 108 (11): 3017.

https://doi.org/10.1182/blood.V108.11.3017.3017

Published: 2006

Journal Articles

Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.

Michael Koldehoff, MD, Ahmet H. Elmaagacli, MD, PH, Nina K. Steckel, MD, Rudolf Trenschel, MD, Michal Hlinka, Markus Ditschkowski, MD, Harald Biersack, MD, Dietrich W. Beelen, MD, PH

Blood (2005) 106 (11): 5355.

https://doi.org/10.1182/blood.V106.11.5355.5355

Published: 2005

Journal Articles

Detection of the Acquired Tyrosine Kinase JAK2 Gene Mutation by Real Time PCR as Minimal Residual Disease Marker for Patients after Allogeneic Hematopoetic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Nina K. Steckel, MD, Michael Koldehoff, MD, Markus Ditschkowski, MD, Rudolf Trenschel, MD, Dietrich W. Beelen, MD

Blood (2005) 106 (11): 1212.

https://doi.org/10.1182/blood.V106.11.1212.1212

Published: 2005

Journal Articles

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Hellmut Ottinger, MD, Koldehoff Michael, MD, Peceny Rudolf, MD, Nina K. Steckel, MD, Rudolf Trenschel, MD, Harald Biersack, MD, Hans Grosse-Wilde, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 974.

https://doi.org/10.1182/blood.V104.11.974.974

Published: 2004

Journal Articles

Mutations Innate Immune System NOD/CARD15 Gene and Toll-Like-Receptor-4 Gene Are Associated with Increased Risk for Severe Acute Gvhd in Patients Who Underwent Allogeneic Transplantation.

Ahmet H. Elmaagacli, M.D., Michael Koldehoff, M.D., Nina K. Steckel, M.D., Heidrun Hindahl, M.D., Rudolf Trenschel, M.D., Hellmut Ottinger, M.D., Dietrich W. Beelen, M.D.

Blood (2004) 104 (11): 425.

https://doi.org/10.1182/blood.V104.11.425.425

Published: 2004

Journal Articles

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Ahmet Elmaagacli, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Rudolf Peceny, MD, Helmut Ottinger, MD, Michael Koldehoff, MD, Harry Biersack, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 3343.

https://doi.org/10.1182/blood.V104.11.3343.3343

Published: 2004

Journal Articles

VEGF Specific siRNAs Act Synergistically with Bortezomib and Steroids in Inhibiting VEGF Gene Expression, Proliferation and Induction of Apoptosis in Multiple Myeloma Cells.

Michael Koldehoff, MD, Nina K. Steckel, Rudolf Trenschel, MD, Dietrich W. Beelen, MD, PH, Ahmet H. Elmaagacli, MD, PH

Blood (2004) 104 (11): 5266.

https://doi.org/10.1182/blood.V104.11.5266.5266

Published: 2004

Journal Articles

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Ahmet Elmaagacli, MD, Helmut Ottinger, MD, Micheal Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 5049.

https://doi.org/10.1182/blood.V104.11.5049.5049

Published: 2004

NARROW

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Matched Unrelated Donor Allogeneic Stem Cell Transplantation in High Risk Acute Lymphoblastic Leukemia (ALL) After a Preparative Regimen of Hyperfractionated Total Body Irradiation and High-Dose Etoposide – A Feasibility Study within the German Multicenter Study Group for Adult ALL.

TLR9 but Not NOD2/CARD15 Gene Polymorphism Influence Outcome in AML-Patients Transplanted From HLA-Identical Sibling Donors.

PKC412 Shows Strong Anti-myeloma effects in in-Vitro-Studies

Reduced Incidence of Severe Acute GVHD in Patients Transplanted from Donors with IL23R (Arg381Gln) Gene Variant.

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.

Detection of the Acquired Tyrosine Kinase JAK2 Gene Mutation by Real Time PCR as Minimal Residual Disease Marker for Patients after Allogeneic Hematopoetic Stem Cell Transplantation.

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Mutations Innate Immune System NOD/CARD15 Gene and Toll-Like-Receptor-4 Gene Are Associated with Increased Risk for Severe Acute Gvhd in Patients Who Underwent Allogeneic Transplantation.

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

VEGF Specific siRNAs Act Synergistically with Bortezomib and Steroids in Inhibiting VEGF Gene Expression, Proliferation and Induction of Apoptosis in Multiple Myeloma Cells.

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only